Develops robotic systems for minimally invasive urologic surgery to treat benign prostatic hyperplasia.
Jun 2026Revenue $337M/yrExpenses $452M/yr
No trendCash runway ≈ 2.7 years from Jun 2026
Figures by year
When will PROCEPT BioRobotics be profitable?
Its figures don’t show a steady enough trend to project a date. In the 12 months to Jun 2026, revenue was $337M and expenses $452M.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Dec 2025 | $308M | $412M | −$104M |
| Dec 2024 | $224M | $321M | −$96.6M |
| Dec 2023 | $136M | $245M | −$109M |
| Dec 2022 | $75.0M | $156M | −$80.7M |
| Dec 2021 | $34.5M | $88.6M | −$54.2M |
| Dec 2020 | $7.72M | $55.5M | −$47.8M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.